Back
Altimmune Stock Predictions
AI Is Disrupting Marketing - Invest in the Shift
Invest Now & Be Part of RAD Intel's Breakout Year
Sell
25
ALT
Altimmune
Last Price:
$5.55
Seasonality Move:
2.69%
7 Day Trial
ALL ACCESS PASS
$
7
AI Is Changing Marketing Forever-Invest Before the Boom
Invest Now & Secure Your Stake in RAD IntelAltimmune Stock Forecast
-
Over the next 52 weeks, Altimmune has on average historically risen by 2.7% based on the past 19 years of stock performance.
-
Altimmune has risen higher in 5 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 26.32%
-
Is Altimmune Stock Undervalued?The current Altimmune [ALT] share price is $5.25. The Score for ALT is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
ALT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Altimmune Stock Go Up Next Year?
-
Over the next 52 weeks, Altimmune has on average historically risen by 2.7% based on the past 19 years of stock performance.
Altimmune Stock Rating
Sell
25
Altimmune (ALT)
is a Sell
Is Altimmune overpriced?
-
Altimmune has risen higher in 5 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 26.32%
Altimmune Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com
52-Week Data
52-Week High:
11.50
52-Week Low:
5.15
Prediction Charts
Market Cap:
404.3M
Price in USD:
5.25
Volume:
3.2M
Beta:
1.18
Technical Analysis
SMA50:
6.70
SMA100:
7.28
SMA200:
7.03
52-Wk Change:
-46.81%
Stock Predictions
-
Is Altimmune stock public?Yes, Altimmune is a publicly traded company.
-
What is the Altimmune stock quote today?The Altimmune stock price is 5.25 USD today.
-
How to buy Altimmune stock online?You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-18 | 6.45 | 6.48 | 6.69 | 6.37 |
| Feb-19 | 6.45 | 6.78 | 7.10 | 6.41 |
| Feb-20 | 6.80 | 6.63 | 6.84 | 6.51 |
| Feb-21 | 6.72 | 6.43 | 6.77 | 6.33 |
| Feb-25 | 6.20 | 5.92 | 6.23 | 5.80 |
| Feb-26 | 5.92 | 5.94 | 6.09 | 5.89 |
| Feb-27 | 6.01 | 6.42 | 6.78 | 5.96 |
| Feb-28 | 6.25 | 6.67 | 6.68 | 6.20 |
| Mar-3 | 6.71 | 5.98 | 6.71 | 5.93 |
| Mar-4 | 5.82 | 5.96 | 6.07 | 5.50 |
| Mar-5 | 5.94 | 5.71 | 6.09 | 5.71 |
| Mar-6 | 5.58 | 5.57 | 5.66 | 5.41 |
| Mar-7 | 5.53 | 5.55 | 5.64 | 5.46 |
| Mar-11 | 5.38 | 5.25 | 5.45 | 5.15 |
Altimmune Earnings
Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.
Altimmune Forecast Revenue Growth
Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.09 per share, an increase this year of $0.16 per share, and a decrease next year of $0.46 per share.
* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.